Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride for Alcohol Use Disorder
NCT04098302Phase 3Completed
- Sponsor
- UConn Health
- Start
- Oct 2019
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutasteride in alcohol use disorder (AUD), sponsored by UConn Health. Started Oct 2019; status: completed.
02
Drugs
dutasteride
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04098302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098302.